1. Home
  2. LGND vs HEES Comparison

LGND vs HEES Comparison

Compare LGND & HEES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • HEES
  • Stock Information
  • Founded
  • LGND 1987
  • HEES 1961
  • Country
  • LGND United States
  • HEES United States
  • Employees
  • LGND N/A
  • HEES N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • HEES Misc Corporate Leasing Services
  • Sector
  • LGND Health Care
  • HEES Industrials
  • Exchange
  • LGND Nasdaq
  • HEES Nasdaq
  • Market Cap
  • LGND 2.0B
  • HEES 2.1B
  • IPO Year
  • LGND 1992
  • HEES 2006
  • Fundamental
  • Price
  • LGND $111.71
  • HEES $58.41
  • Analyst Decision
  • LGND Strong Buy
  • HEES Buy
  • Analyst Count
  • LGND 6
  • HEES 6
  • Target Price
  • LGND $144.83
  • HEES $61.25
  • AVG Volume (30 Days)
  • LGND 142.9K
  • HEES 332.0K
  • Earning Date
  • LGND 11-07-2024
  • HEES 10-29-2024
  • Dividend Yield
  • LGND N/A
  • HEES 1.88%
  • EPS Growth
  • LGND 160.46
  • HEES N/A
  • EPS
  • LGND 2.47
  • HEES 3.94
  • Revenue
  • LGND $152,422,000.00
  • HEES $1,518,307,000.00
  • Revenue This Year
  • LGND $23.19
  • HEES $4.55
  • Revenue Next Year
  • LGND $15.08
  • HEES $3.91
  • P/E Ratio
  • LGND $45.20
  • HEES $14.83
  • Revenue Growth
  • LGND N/A
  • HEES 5.69
  • 52 Week Low
  • LGND $57.00
  • HEES $40.92
  • 52 Week High
  • LGND $129.90
  • HEES $66.18
  • Technical
  • Relative Strength Index (RSI)
  • LGND 48.80
  • HEES 62.56
  • Support Level
  • LGND $119.69
  • HEES $58.66
  • Resistance Level
  • LGND $125.76
  • HEES $60.66
  • Average True Range (ATR)
  • LGND 5.73
  • HEES 1.86
  • MACD
  • LGND -0.30
  • HEES 0.28
  • Stochastic Oscillator
  • LGND 25.51
  • HEES 77.92

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About HEES H&E Equipment Services Inc.

H&E Equipment Services Inc is an integrated equipment services company. It is focused on heavy construction and industrial equipment. It rents, sells, and provides parts and services support for four core categories of equipment including hi-lift or aerial work platform equipment, cranes, earthmoving equipment, and industrial lift trucks. It engages in five principal business activities: equipment rentals; new equipment sales; sales of rental equipment; parts sales; and services. The majority of its revenue is derived from the equipment rentals segment.

Share on Social Networks: